Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Oral Hypoglycemic Agents: Sulfonylureas
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 1, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Chia-Fa Lin1, Tsung-Hung Chueh1, Cheng-Hsun Chung1
1School of Life Science, National Taiwan Normal University, Taipei, 11677, Taiwan.
Sulforaphane, an Nrf-2 activator, ameliorates diabetes-induced voiding dysfunction by reducing oxidative stress, endoplasmic reticulum stress, and apoptosis in the bladder. This antioxidant treatment improves bladder function in diabetic models.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: